“We've contemplated that into our guidance for 2023. And the overall impact is modest relative to historical declines in price in prior years. We expect that to continue to be in that mid-single-digit decline in price in Europe.”

In context

“y on this front. So, I know it's only been sort of 45 days or so since you made those comments, but any advances in sort of how you're thinking about this? And any specific products or countries we should think about that impact? Thank you. Joe Fletcher: Thanks Carter for the question. I'm actually going to hand this over to Ilya Yuffa, who's our President of Lilly International to comment on the European austerity measures. Ilya Yuffa: Yes, I appreciate the question. There have been a number of markets in Europe that have taken some austerity measures, partially due to Ukraine crisis and energy crisis and inflation in Europe. We have seen Germany, France, obviously, the UK, voluntary system we think is broken and so we exited that. And so we -- there are some austerity measures in there. We've contemplated that into our guidance for 2023. And the overall impact is modest relative to historical declines in price in prior years. We expect that to continue to be in that mid-single-digit decline in price in Europe. Joe Fletcher: Thanks Ilya. Thanks Carter for the question. Lois, next question. Operator: The next question is from Andrew Baum from Citi. Please go ahead. Andrew Baum: Thank you. A question on US commercial access for GLP-1 agonist. First, could you share with us how you're thinking about modeling the impact of the IRA in terms of GLP-1 uptake increasing as a result of the co-pay cap? And additionally benefiting from the reduction in free drug program. How significant is it given the patients still got to find $2,000 per annum? And then second, in relation to the oral DPP-4 market which is still a very, very substantial $14 billion market. You have a category of drugs extensively which may offer considerable advantages in efficacy for glycemia and white. But I'm reminded of the stickines”